Nanoparticles disguised as red blood cells; Depomed alleges patent infringement against Sun;

> Nanoparticles disguised as red blood cells deliver cancer-fighting drugs. More here

> Depomed has filed a patent infringement lawsuit against Sun Pharmaceutical Industries, alleging Sun intends to market generic Glumetza (metformin hydrochloride extended release tablets) before the expiration of Depomed's patents. Release

> To bypass the blood-brain barrier, drugs can be delivered through the nose to target the brain, says a researcher in Egypt. Report

> Could remote drug delivery gadgets be hacked? Blog post

> Pulmatrix introduces inhaled dry powder drug delivery platform iSPERSE. Story

And Finally... Futura Medical's "erection enhancing" condom CSD500, which "incorporates an erectogenic compound" to help men stay firmer during intercourse, has been recommended for European approval. The big story

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.